skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 201740 Find in a Library
Title: Pilot Randomized Double Blind Placebo-controlled Study of Dexamphetamine for Cocaine Dependence
Journal: Addiction  Volume:98  Issue:8  Dated:August 2003  Pages:1137-1141
Author(s): James Shearer; Alex Wodak; Ingrid van Beek; Richard P. Mattick; John Lewis
Date Published: August 2003
Page Count: 5
Type: Report (Study/Research)
Format: Article
Language: English
Country: United States of America
Annotation: This article discusses the feasibility of conducting a placebo-controlled clinical trial of dexamphetamine replacement therapy for cocaine dependence.
Abstract: In a double-blind randomized placebo-controlled trial, 30 cocaine-dependent injecting drug users were assigned to receive 60 mg/day dexamphetamine or placebo for 14 weeks. Immunoassay and mass spectrometric techniques were used to identify cocaine metabolites in urine. Subjects were screened using the Composite International Diagnostic Interview and DSM-IV. To collect pre- and post-self-report data, the Opiate Treatment Index, Brief Symptom Inventory, Severity of Dependence Scale, and visual analogue craving scales were used. The results show that the response to the intervention among a difficult to engage and treat population was encouraging. Outcomes favored the treatment group in terms of cocaine use measured by urinalysis and self-report, crime, cocaine craving, and severity of cocaine dependence, with no improvements observed in the placebo group. The results supported the specific efficacy of dexamphetamine in attenuating cocaine craving. The findings in the psychological dimension of dependence were supported further by declines found in the severity of cocaine dependence scores. The intervention and study design appeared to be acceptable to cocaine users, as evidenced by satisfactory recruitment and retention in an otherwise highly chaotic group. Further controlled studies are advised with adequate power to evaluate the utility of dexamphetamine in the management of cocaine dependence. 1 figure, 1 table, 14 references
Main Term(s): Cocaine; Drug treatment
Index Term(s): Controlled Substances; Drug abuse; Drug dependence; Drug detoxification; Drug research; Treatment
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.